You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The French firm reached five new deals covering 15 countries for its Immunoscore test, which helps physicians assess colon cancer prognosis.
Developers claim the immunochromatographic assay has advantages over other tests on the market for diagnosing TB in HIV patients, as well as the conventional approach.
The company also published a study describing ImmRay PanCan-D biomarker signature that it said could be used to detect early-stage pancreatic cancer.
Atomo's tests use the firm's AtomoRapid technology to detect the presence of HIV antibodies from a finger prick of blood and provides results within 15 minutes.
The goal of the project is to develop a strategy that will increase demand for and access to HIV self-testing among at-risk Nigerian youths.
TSG is a wholly owned subsidiary of Ascendis Medical and supplies diagnostic laboratory equipment and consumables to pathology laboratories.
As part of the agreements, the distributors have committed to purchase a minimum number of Curetis' molecular diagnostic systems over three years.